Environmental risk assessment of fluoxetine A case study with a human pharmaceutical
A. Coors
(1)
,
K. Oakes
(2)
,
B. Escher
(3)
,
Kathrin Fenner
(3)
,
Jeanne Garric
(4)
,
M. Gust
(4)
,
T. Knacker
(1)
,
A. Kuester
(5)
,
C. Kussatz
(5)
,
P. Lopez-Mancisidor
(6)
,
C. Metcalfe
(7)
,
S. Monteiro
(8)
,
T. Moon
(9)
,
J. Parrott
(10)
,
Alexandre R.R. Pery
(11)
,
M. Ramil
(12)
,
P. Sanchez Arguello
(6)
,
M. Servos
(2)
,
T.A. Ternes
(12)
,
V. Trudeau
(9)
,
G. van Der Kraak
(13)
1
Eokotoxikologie GmbH
2 University of Waterloo [Waterloo]
3 Swiss Federal Institute of Aquatic Science and Technology
4 UR BELY - Biologie des écosystèmes aquatiques
5 UBA - German Federal Environmental Agency / Umweltbundesamt
6 INIA
7 Trent University of Ottawa
8 Central Science Laboratory
9 University of Ottawa [Ottawa]
10 Environment and Climate Change Canada
11 INERIS - Institut National de l'Environnement Industriel et des Risques
12 Bundesanstalt fur Gewasserkunde
13 University of Guelph
2 University of Waterloo [Waterloo]
3 Swiss Federal Institute of Aquatic Science and Technology
4 UR BELY - Biologie des écosystèmes aquatiques
5 UBA - German Federal Environmental Agency / Umweltbundesamt
6 INIA
7 Trent University of Ottawa
8 Central Science Laboratory
9 University of Ottawa [Ottawa]
10 Environment and Climate Change Canada
11 INERIS - Institut National de l'Environnement Industriel et des Risques
12 Bundesanstalt fur Gewasserkunde
13 University of Guelph